This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Email citation

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Review

. 2016 Mar 29:7:79-82.

doi: 10.1016/j.amsu.2016.03.028. eCollection 2016 May.

Thromboangiitis obliterans (Buerger's disease)

Ignacio J Rivera-Chavarría¹, José D Brenes-Gutiérrez¹

Affiliations

PMID: 27144003
PMCID: PMC4840397
DOI: 10.1016/j.amsu.2016.03.028

Review

Thromboangiitis obliterans (Buerger's disease)

Ignacio J Rivera-Chavarría et al. Ann Med Surg (Lond). 2016.

. 2016 Mar 29:7:79-82.

doi: 10.1016/j.amsu.2016.03.028. eCollection 2016 May.

Authors

Ignacio J Rivera-Chavarría¹, José D Brenes-Gutiérrez¹

Affiliation

¹ Division of Vascular Surgery, Rafael Ángel Calderón Guardia Hospital, Caja Costarricense del Seguro Social, San José, Costa Rica.

PMID: 27144003
PMCID: PMC4840397
DOI: 10.1016/j.amsu.2016.03.028

Abstract

Thromboangiitis Obliterans is a non-atherosclerotic inflammatory disease of unknown etiology, which has a strong association with tobacco. We present current concepts on the pathophysiology and diagnosis, as well as a review in treatments.

Keywords: Buerger's disease; Thromboangiitis obliterans; Tobacco.

PubMed Disclaimer

Similar articles

Autoimmune mechanisms in thromboangiitis obliterans (Buerger's disease): the role of tobacco antigen and the major histocompatibility complex.
Papa M, Bass A, Adar R, Halperin Z, Schneiderman J, Becker CG, Brautbar H, Mozes E. Papa M, et al. Surgery. 1992 May;111(5):527-31. Surgery. 1992. PMID: 1598672
Thromboangiitis obliterans (Buerger's disease).
Olin JW, Shih A. Olin JW, et al. Curr Opin Rheumatol. 2006 Jan;18(1):18-24. doi: 10.1097/01.bor.0000198000.58073.aa. Curr Opin Rheumatol. 2006. PMID: 16344615 Review.
Thromboangiitis obliterans (Buerger's disease) with intestinal involvement--a case report.
Núñez Garcia A, López Cubero L, Rico Zalba L, Molíns Otero A, Gómez Octavio J, Arribas A. Núñez Garcia A, et al. Angiology. 1998 Jun;49(6):489-92. doi: 10.1177/000331979804900611. Angiology. 1998. PMID: 9631896
Thromboangiitis obliterans: an old disease in need of a new look.
Adar R, Papa MZ, Schneiderman J. Adar R, et al. Int J Cardiol. 2000 Aug 31;75 Suppl 1:S167-70; discussion S171-3. doi: 10.1016/s0167-5273(00)00185-6. Int J Cardiol. 2000. PMID: 10980358
Imaging appearances of Buerger's disease complications in the upper and lower limbs.
Dimmick SJ, Goh AC, Cauzza E, Steinbach LS, Baumgartner I, Stauffer E, Voegelin E, Anderson SE. Dimmick SJ, et al. Clin Radiol. 2012 Dec;67(12):1207-11. doi: 10.1016/j.crad.2012.04.005. Epub 2012 Jul 9. Clin Radiol. 2012. PMID: 22784658 Review.

See all similar articles

Cited by

Gene Therapy of Thromboangiitis Obliterans with Growth Factor Plasmid (VEGF165) and Autologous Bone Marrow Cells.
Barć P, Lubieniecki P, Antkiewicz M, Kupczyńska D, Barć J, Frączkowska-Sioma K, Dawiskiba T, Dorobisz T, Sekula W, Czuwara B, Małodobra-Mazur M, Baczyńska D, Witkiewicz W, Skóra JP, Janczak D. Barć P, et al. Biomedicines. 2024 Jul 6;12(7):1506. doi: 10.3390/biomedicines12071506. Biomedicines. 2024. PMID: 39062079 Free PMC article.
Raynaud's Phenomenon: A Current Update on Pathogenesis, Diagnostic Workup, and Treatment.
Ture HY, Lee NY, Kim NR, Nam EJ. Ture HY, et al. Vasc Specialist Int. 2024 Jul 23;40:26. doi: 10.5758/vsi.240047. Vasc Specialist Int. 2024. PMID: 39040029 Free PMC article. Review.
Comparative Analysis of Transcriptome Profiles in Patients with Thromboangiitis Obliterans.
Öztan G, Bozbuğa N, İşsever H, Oğuz F, Canıaz İ, Yazıksız N, Ertan M, Alpagut İU. Öztan G, et al. Genes (Basel). 2023 Dec 21;15(1):19. doi: 10.3390/genes15010019. Genes (Basel). 2023. PMID: 38275601 Free PMC article.
Assessing Mailuoning injection in wound healing and thrombophlebitis management: A rat model study.
Xiao J, Xie Y, Liu J, Liu T, Ye R, Duan X, Le Z, Deng N, Duan Q. Xiao J, et al. Int Wound J. 2024 Apr;21(4):e14527. doi: 10.1111/iwj.14527. Epub 2023 Dec 14. Int Wound J. 2024. PMID: 38095110 Free PMC article.
Knowledge Mapping of Global Status and Trends for Thromboangiitis Obliterans: A Bibliometrics and Visual Analysis.
Liu Z, Zhou C, Guo H, Wang M, Liang J, Zhang Y. Liu Z, et al. J Pain Res. 2023 Nov 30;16:4071-4087. doi: 10.2147/JPR.S437521. eCollection 2023. J Pain Res. 2023. PMID: 38054111 Free PMC article.

See all "Cited by" articles

References

1. Ates A., Yekeler I., Ceviz M., Erkut B., Pac M., Basoglu A. One of the most frequent vascular diseases in northeastern of Turkey: thromboangiitis obliterans or Buerger's disease (experience with 344 cases) Int. J. Cardiol. 2006;111:147–153. - PubMed
1. Batsis J., Kulsum K. Thromboangiitis obliterans (Buerger disease) Mayo Clin. Proc. 2007;82:448. - PubMed
1. Hartmann P., Mohokum M., Schlattmann P. The association of Raynaud syndrome with thromboangiitis obliterans a meta-analysis. Angiology. 2012;63:315–319. - PubMed
1. Kröger K. Buerger's disease: what has the last decade taught us? Eur. J. Intern. Med. 2006;17:227–234. - PubMed
1. Yun H., Kim D., Lee K., Lim S., Hwang W., Yun S. End stage renal disease caused by thromboangiitis obliterans: a case report. J. Med. Case Rep. 2015;9:174. - PMC - PubMed

Publication types

Actions

LinkOut - more resources

Full Text Sources
Other Literature Sources
- The Lens - Patent Citations Database
- scite Smart Citations